These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9207281

  • 41. [Osteopenia in primary biliary cirrhosis. Study in 20 patients].
    Pumarino H, Brahm J, Oviedo S, Lillo R, González P.
    Rev Med Chil; 1994 Dec; 122(12):1398-403. PubMed ID: 7659915
    [Abstract] [Full Text] [Related]

  • 42. Treatment of bone loss in osteopenic patients with Crohn's disease: a double-blind, randomised trial of oral risedronate 35 mg once weekly or placebo, concomitant with calcium and vitamin D supplementation.
    van Bodegraven AA, Bravenboer N, Witte BI, Dijkstra G, van der Woude CJ, Stokkers PC, Russel MG, Oldenburg B, Pierik M, Roos JC, van Hogezand RA, Dik VK, Oostlander AE, Netelenbos JC, van de Langerijt L, Hommes DW, Lips P, Dutch Initiative on Crohn and Colitis (ICC).
    Gut; 2014 Sep; 63(9):1424-30. PubMed ID: 24146170
    [Abstract] [Full Text] [Related]

  • 43. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis.
    Olsson R, Mattsson LA, Obrant K, Mellström D.
    Liver; 1999 Jun; 19(3):188-92. PubMed ID: 10395037
    [Abstract] [Full Text] [Related]

  • 44. Cyclic oral phosphate and etidronate increase femoral and lumbar bone mineral density and reduce lumbar spine fracture rate over three years.
    Silberstein EB, Schnur W.
    J Nucl Med; 1992 Jan; 33(1):1-5. PubMed ID: 1730972
    [Abstract] [Full Text] [Related]

  • 45. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T, Kollerup G, Thamsborg G, Genant HK, Sørensen OH.
    J Rheumatol; 1996 Sep; 23(9):1560-4. PubMed ID: 8877926
    [Abstract] [Full Text] [Related]

  • 46. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
    Roux C, Oriente P, Laan R, Hughes RA, Ittner J, Goemaere S, Di Munno O, Pouillès JM, Horlait S, Cortet B.
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1128-33. PubMed ID: 9543129
    [Abstract] [Full Text] [Related]

  • 47. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats.
    Katsumata T, Nakamura T, Ohnishi H, Sakurama T.
    J Bone Miner Res; 1995 Jun; 10(6):921-31. PubMed ID: 7572316
    [Abstract] [Full Text] [Related]

  • 48. Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.
    Murphy KJ, Line BR, Malfetano J.
    Can Assoc Radiol J; 1997 Jun; 48(3):199-202. PubMed ID: 9193420
    [Abstract] [Full Text] [Related]

  • 49. Ursodeoxycholic acid enhances fractional calcium absorption in primary biliary cirrhosis.
    Verma A, Maxwell JD, Ang L, Davis T, Hodges S, Northfield TC, Zaidi M, Pazianas M.
    Osteoporos Int; 2002 Aug; 13(8):677-82. PubMed ID: 12181628
    [Abstract] [Full Text] [Related]

  • 50. [The clinical benefits to bone mineral density were shown by cyclical oral etidronate administration in steroid induced osteoporosis].
    Nakamura T, Maekawa S, Morinobu S, Morinobu A, Koshiba M, Yamauchi M, Sugimoto T, Kumagai S.
    Ryumachi; 2002 Aug; 42(4):666-75. PubMed ID: 12355861
    [Abstract] [Full Text] [Related]

  • 51. Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke.
    Sato Y, Asoh T, Kaji M, Oizumi K.
    J Bone Miner Res; 2000 Dec; 15(12):2487-94. PubMed ID: 11127214
    [Abstract] [Full Text] [Related]

  • 52. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ, Ioannidis G, Adachi JD, Bensen WG, Bianchi F, Cividino A, Gordon M, Kaminska E, Scocchia T, Petrie A, Stephenson GF, Goldsmith CH.
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [Abstract] [Full Text] [Related]

  • 53. Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.
    Campbell IA, Douglas JG, Francis RM, Prescott RJ, Reid DM, Research Committee of the British Thoracic Society.
    Thorax; 2004 Sep; 59(9):761-8. PubMed ID: 15333852
    [Abstract] [Full Text] [Related]

  • 54. Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis.
    Guañabens N, Monegal A, Cerdá D, Muxí Á, Gifre L, Peris P, Parés A.
    Hepatology; 2013 Dec; 58(6):2070-8. PubMed ID: 23686738
    [Abstract] [Full Text] [Related]

  • 55. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M.
    J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
    [Abstract] [Full Text] [Related]

  • 56. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up).
    Meunier PJ, Confavreux E, Tupinon I, Hardouin C, Delmas PD, Balena R.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2784-91. PubMed ID: 9284696
    [Abstract] [Full Text] [Related]

  • 57. The effect of strength training combined with bisphosphonate (etidronate) therapy on bone mineral, lean tissue, and fat mass in postmenopausal women.
    Chilibeck PD, Davison KS, Whiting SJ, Suzuki Y, Janzen CL, Peloso P.
    Can J Physiol Pharmacol; 2002 Oct; 80(10):941-50. PubMed ID: 12450060
    [Abstract] [Full Text] [Related]

  • 58. Cyclical etidronate increases lumbar spine bone density in patients on long-term glucocorticosteroid therapy.
    Skingle SJ, Moore DJ, Crisp AJ.
    Int J Clin Pract; 1997 Sep; 51(6):364-7. PubMed ID: 9489064
    [Abstract] [Full Text] [Related]

  • 59. Effect of intermittent cyclical etidronate therapy on corticosteroid induced osteoporosis in Japanese patients with connective tissue disease: 3 year followup.
    Sato S, Ohosone Y, Suwa A, Yasuoka H, Nojima T, Fujii T, Kuwana M, Nakamura K, Mimori T, Hirakata M.
    J Rheumatol; 2003 Dec; 30(12):2673-9. PubMed ID: 14719212
    [Abstract] [Full Text] [Related]

  • 60. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
    Adachi J, Cranney A, Goldsmith CH, Bensen WG, Bianchi F, Cividino A, Craig GL, Kaminska E, Sebaldt RJ, Papaioannou A.
    J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.